Amante, F.H., et al. " A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design." Journal of Immunology 159 (1997): 5535-5544.

Binka, F.N., et al. "Impact of permethrin impregnated bednets on child mortality in Kassena-Nankana district, Ghana: a randomized controlled trial." Tropical Medicine and International Health 1 (1996): 147-154.

Cavanagh, D.R., et al. "A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan." Journal of Immunology 161 (1998): 347-359.

Chaba, B, et al. "Influence of immunoadjuvants and a promiscous T-cell determinant on the immunogenicity of RESA peptide antigen of P. falciparum." International Journal of Immunopharmacology 20 (1998): 259-273.

Clough, B. "Plasmodium falciparum lacks sialidase and trans-sialidase activity." Parasitology 112 (1996): 443-449.

Cooke, B.M., et al. "A recombinant peptide based on PfEMP-1 blocks and reverses adhesion of malaria-infected red blood cells to CD36 under flow." Molecular Microbiology 30 (1998): 83-90.

Cullinan, TR and Pieterick, C. "Packaged treatment for first-line care in cerebral malaria and meningitis." World Health Organization Bulletin 76 (1998): 257-264.

Curtis, C.F. (1994) Should DDT continue to be recommended for malaria vector control? Medical & Veterinary Entomology 8, 107-112.

Division of Laboratory Services at Royal Perth Hospital (RPH). Malaria: an on-line resource. Online. Available: http://www.rph.wa.gov.au/labs/haem/malaria/index.html. 10 March 1999.

Doolan, D.L. and S.L. Hoffman. "Multi-gene Vaccination against Malaria: A Multistage, Multi-immune Response Approach." Parasitology Today 13 (1997): 171-177.

Duffy, P.E. and Michael Fried. "Maternal Malaria and Parasite Adhesion." Journal of Molecular Medicine. 76 (1998): 162-171.

Hollingdale, M.R. "Biology of Malaria Liver Stages: implications for vaccine design." Annals of Tropical Medicine and Parasitology 92 (1998): 411-417.

Lyon, J.A., et al. "Merozoite surface protein-1 epitopes recognized by antibodies that inhibit Plasmodium falciparum merozoite dispersal." Molecular and Biochemical Parasitology 90 (1997): 223-234.

Nardin, Elizabeth H. and Ruth S. Nussenzweig. "Vaccines Against Malaria: Part I: Synthetic Peptide Vaccines Against the Sporozoite Stage of Plasmodium." New Generation Vaccines. Woodrow & Levine.

Newton, Charles R. J. C., and Warrell, David A. "Neurological Manifestations of Falciparum Malaria." Annals of Neurology 43 (1998): 695-702.

Newton, CR and Krishna, S. "Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment." Pharmacology and Therapeutics 79 (1998): 1-53.

Qari, S.H., et al. "Predicted and observed alleles of Plasmodium falciparum merozoite surface protein-1 (MSP-1), a potential malaria vaccine antigen." Molecular and Biochemical Parasitology 92 (1998): 241-252.

Ramasamy, Ranjan. "Molecular Basis of Host Immunity and Pathogenesis in Malaria." Bichimica et Biophysica Acta 1406 (1998): 10-27.

Sharma, YD. "Knob proteins in falciparum malaria." Indian Journal of Medical Research 106 (1997): 53-62.

Shi, Ya Ping, et al. "Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine." Proc. Natl. Acad. Sci. USA 96 (1999): 1615-1620.

Siddique, A.B., et al. "Antibodies to sequences in a non-repeat region of Plasmodium falciparum antigen Pf155/RESA inhibit either cytoadherence or parasite growth in vitro." Parasitology 117, Part 3 (1998): 209-216.

Staalso, T, et al. " Antibody reactivity to conserved linear epitopes of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1)." Immunology Letters 60(2-3) (1998): 121-126.

Taylor, R.R., et al. "IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria." American Journal of Tropical Medicine and Hygiene 58 (1998): 406-413.

Udhayakumar,V. "Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC)." Vaccine 16 (1998): 982-988.

Wang, Ruobing, et al. "Induction of Antigen-Specific Cytotoxic T Lymphocytes in Humans by a Malaria DNA Vaccine." Science 282 (1998): 476-479.

World Health Organization. Malaria Prevention and Control. Online. WHO/CTD. Available: http://www.who.int/ctd/html/malaria.html. 25 February 1999.

Zevering, Y, et al. "Human and murine T-cell responses to allelic forms of a malaria circumsporozoite protein epitope support a polyvalent vaccine strategy." Immunology 94 (1998): 445-454.